Results 71 to 80 of about 427 (123)

Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2. [PDF]

Int J Mol Sci
Rudy LM, Godlewski MM.
europepmc   +1 more source

Se-duction is not sex-duction: Desexualizing and de-feminizing hysteria. [PDF]

Front Psychol, 2022
Mancini M, Scudiero M, Mignogna S, Urso V, Stanghellini G.   +4 more
europepmc   +1 more source

Misidentification syndrome: A narrative review. [PDF]

Ind Psychiatry J
Grover S, Yadav N, Saini Y, Sharma N.
europepmc   +1 more source

The frequency of psychotic symptoms in types of dementia: a systematic review. [PDF]

Dement Neuropsychol, 2023
Pessoa RMP, Maximiano-Barreto MA, Lambert L, Leite ÉDM, Chagas MHN.   +4 more
europepmc   +1 more source

Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database. [PDF]

Front Pharmacol
Liu R, Liu C, Feng D, Guo T, Wang Y.
europepmc   +1 more source

Psychiatric Adverse Events Associated With Dihydropyridine Calcium Channel Blockers: A Pharmacovigilance Study Based on FAERS Database. [PDF]

Clin Neuropharmacol
Jiang H, Lin Y, Tu L, Hong Q.
europepmc   +1 more source

Is there a risk of esketamine misuse in clinical practice? [PDF]

Ther Adv Drug Saf
Roncero C, Merizalde-Torres M, Szerman N, Torrens M, Vega P, Andres-Olivera P, Javier Álvarez F.   +6 more
europepmc   +1 more source

Recent Insights Into Sleep Paralysis: Mechanisms and Management. [PDF]

Cureus
Bhalerao V, Gotarkar S, Vishwakarma D, Kanchan S.   +3 more
europepmc   +1 more source

A real-world pharmacovigilance study of esketamine nasal spray. [PDF]

Medicine (Baltimore)
Chen Y, Gu H, Li W, Chen Y.
europepmc   +1 more source